Did you look into RXII before you invested? They don't even have a drug in development. If I wanted to partner with a firm in this area then I'd do it with ISIS or Regulus.
I'm sick that ISIS couldn't hold $11 today. TEVA discontinued development of ATL1102 with ANP so that could have given a few investors reason to sell in addition to GENZ's problems.